<DOC>
	<DOCNO>NCT02759536</DOCNO>
	<brief_summary>Boron Neutron Capture Therapy ( BNCT ) use treatment several type malignant tumor , include malignant melanoma , high-grade glioma , advanced head neck cancer . Theoretically , represent precise radiotherapy could spare normal cell destroy malignant one . However , value largely restrict fact could perform nuclear research reactor , neutron source time . In 2010 , world 's first in-hospital neutron irradiator ( IHNI ) construct Beijing , China , study aim evaluate whether IHNI potential serve effective in-hospital neutron source BNCT .</brief_summary>
	<brief_title>In-hospital Neutron Irradiator ( IHNI ) -Based Boron Neutron Capture Therapy ( BNCT ) Treatment Malignant Melanoma</brief_title>
	<detailed_description>This single BNCT-facility , non-randomized , non-comparative , open-label , phase I II clinical trial determine value IHNI performance BNCT . Before patient recruit study , must confirm malignant melanoma biopsy pathological analysis . Then receive boron bio-distribution test , patient whose boron concentration tumor tissue &gt; 1.5 time blood enrol . Before patient irradiated IHNI , infused Boronophenylalanine ( BPA ) -fructose solution intravenously dose 350mg/kg 90 minute , blood withdrawn patient different time point measure boron concentration . The start point duration irradiation determine base boron concentration blood boron bio-distribution curve . IHNI locate Fangshan District , Beijing , China . The recruitment patient , evaluation medical care BNCT do Third Xiangya Hospital , Changsha , China . All patient evaluate response biopsy pathological analysis , Positron Emission Computed Tomography ( PET-CT ) , Computed Tomography ( CT ) magnetic resonance imaging ( MRI ) .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Boron</mesh_term>
	<criteria>1 . Sign inform consent form . 2 . Age 18 , gender unlimited . 3 . Expectation life 3 month . 4 . Characteristic disease : ① Pathological analysis confirms diagnosis melanoma . ② PETCT serum lactate dehydrogenase ( LDH ) use auxiliary diagnosis . ③Diameter least one solid tumor ≥ 1cm . 5 . KPS score : ≥70 % . 6 . Eastern Cooperative Oncology Group ( ECOG ) score : 02 grade . 7 . ( Within week ) Complete blood count : hemoglobin≥90g/L , leukocyte ≥ 4.0×109/L , neutrophilic granulocyte ≥ 2.0×109/L , platelet ≥ 100.0×109/L ; Renal function : creatinine ≤ 180 umol/L . 8 . Never accept radiation chemotherapy , interval radiation chemotherapy administer 3 month . 9 . Never accept target drug biotherapeutics . 10 . Urine pregnancy test negative ( selectivity ) . 1 . Intolerable BNCT treatment . 2 . Sever coagulation disorder . 3 . Poor compliance . 4 . Sever complication infection without control . 5 . Pregnant woman woman lactation period . 6 . Patients metallic instrument ( pacemaker , artificial limb ) . 7 . Boron concentration tumor tissue &lt; 1.5 time blood . 8 . Age &lt; 18 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>